Avadel Pharmaceuticals

From Wikipedia, the free encyclopedia

Avadel Pharmaceuticals plc
Typeplc
Nasdaq: AVDL
IndustryHealthcare – Pharmaceutical
Founded1990
Headquarters
Dublin
,
Ireland
Key people
 (CEO, Director)
Michael F. Kanan ( Chief Financial Officer )
Revenue$ 150.2M (Dec31, 2016)[1]
Websitewww.avadel.com

Avadel Pharmaceuticals plc Nasdaq: AVDL, is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.[2]

The company was founded as Flamel Technologies SA in Lyon, France in 1990.[3]

The company acquired Éclat Pharmaceuticals of St. Louis, Missouri in March 2012.[4][5]

On 8 February 2016, the company acquired FSC Holdings, LLC, which included its wholly owned subsidiaries FSC Pediatrics, Inc., FSC Therapeutics, LLC, and FSC Laboratories, Inc.[6]

On 3 January 2017, Flamel, Éclat, and FCS Pediatrics became Avadel Pharmaceuticals plc after the Company completed a cross-border merger from France to Ireland.[7]

In 2019, Mike Anderson, CEO of Avadel Pharmaceuticals has resigned, and Gregory Divis, COO of the company was appointed as his temporary successor. Meanwhile, Craig Stapleton, chairman of the Dublin-headquartered Avadel, has also stepped down.[8]

References[]

  1. ^ "Company Key Statistics".
  2. ^ "Investor Home". investors.avadel.com. Retrieved 26 June 2017.
  3. ^ "Presentations | Investors | Avadel Pharmaceuticals". investors.avadel.com. Retrieved 17 July 2017.
  4. ^ "About Us". eclatpharma.com. Retrieved 29 December 2014.
  5. ^ "Flamel Technologies Announces Acquisition of Éclat Pharmaceuticals". businesswire.com. 14 March 2012. Retrieved 29 December 2014.
  6. ^ "Flamel Technologies Acquires FSC Pediatrics". marketwired.com. 8 February 2016. Retrieved 7 March 2017.
  7. ^ "Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc". globenewswire.com. 3 January 2017. Retrieved 7 March 2017.
  8. ^ "Avadel chief executive resigns suddenly". The Irish Times. 3 January 2019. Retrieved 30 October 2020.

External links[]

Retrieved from ""